nach oben

Reactions Weekly

Erschienen in:

01.08.2019 | Case report

Vedolizumab

Infusion related reaction with fever, chills and invesive fungal infection following off label use: 3 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

In a retrospective analysis of 29 patients, three patients [ages and sexes not stated] were described, of which, one patient experienced infusion related reaction with fever and chills; and two patients developed invasive fungal infection following off label use of vedolizumab for treatment of steroid-resistant severe intestinal acute graft versus host disease (GVHD). …

Danylesko I, et al. Anti-alpha4beta7 integrin monoclonal antibody (vedolizumab) for the treatment of steroid-resistant severe intestinal acute graft-versus-host disease. Bone Marrow Transplantation 54: 987-993, No. 7, 2019. Available from: URL: http://doi.org/10.1038/s41409-018-0364-5 - Israel

Titel: Vedolizumab
Infusion related reaction with fever, chills and invesive fungal infection following off label use: 3 case reports
Publikationsdatum: 01.08.2019
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-019-66069-5

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Vedolizumab

Infusion related reaction with fever, chills and invesive fungal infection following off label use: 3 case reports

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2019

Fluorouracil/folinic acid/oxaliplatin

Carvedilol

Doxorubicin liposomal

Isopropyl-alcohol

Dexamethasone/methylprednisolone/rituximab

Heparin/low molecular weight heparins